A Phase 2 Study of Linsitinib (OSI-906) in Pediatric and Adult Wild Type Gastrointestinal Stromal Tumors

TYPE OF SARCOMA: Gastrointestinal stromal tumors
DRUG: OSI-906
ACCRUAL STATUS: Completed

OVERALL STUDY PRINCIPAL INVESTIGATOR:
Margaret von Mehren, MD
Fox Chase Cancer Center

CLINICALTRIALS.GOV IDENTIFIER: NCT01560260

FOR STUDY DETAILS AND ELIGIBILITY CRITERIA: CLINICALTRIALS.GOV

To learn more about this study or to contact the study research staff: